Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen
We summarize here clinical and trial data on a once-daily administration of a single bolus to the meal with the largest expected postprandial glucose excursion (basal-plus), and comment on its clinical utility in the treatment of type 2 diabetes. A PubMed search of data published until September 201...
Saved in:
| Main Authors: | Peter Bramlage, Anja Borck, Jochen Seufert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000679.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: G. A. Galkina, et al.
Published: (2015-10-01) -
Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
by: Yuka Tosaka, et al.
Published: (2015-01-01) -
Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
by: Natalya Nikitichna Volevodz, et al.
Published: (2013-03-01) -
The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
by: Vadim V. Klimontov, et al.
Published: (2015-12-01) -
Intelligent Dual Basal–Bolus Calculator for Multiple Daily Insulin Injections via Offline Reinforcement Learning
by: Junyoung Yoo, et al.
Published: (2024-01-01)